NCT04576403

Brief Summary

The primary objective of this trial is to assess the efficacy of an intervention with heated mittens in patients with hand osteoarthritis (HOA). The joints of the hands are some of the most commonly joints affected by osteoarthritis, together with hip and knee joints. The prevalence increases with age and as the elderly population is growing so will the number of persons with HOA. The primary symptoms for HOA are reduced function, stiffness and pain, with function being the most limiting factor for the patients. Pharmacological treatments have some effect. Non-pharmacological treatments (such as exercise) have been investigated in a limited number of studies with overall minimal effect on the primary symptoms. In the earlier days the use of heating interventions, such as paraffin bath, was common treatment for patients with arthritis. During the last decades a shift from heating to exercise oriented treatment has occurred, however seemingly with limited effect on the primary symptoms. American College of Rheumatology (ACR) newest published guideline for the management of HOA (2020) recommend heating as a treatment among others but without scientific sound evidence for effect. The hypothesis is that heated mittens worn at least 15 minutes every day for six weeks has a beneficial effect on physical function in patient with HOA when compared to placebo mittens (heat deactivated). This study is designed as a randomized controlled trial with two parallel groups (1:1) and physical function of the hand as primary endpoint after six weeks. The plan is to include 200 patients with HOA for this study. The intervention group will receive mittens with functioning heating elements; the control group will receive mittens without a functioning heating element. All participants are asked to wear the mittens for 6 weeks, 15 minutes each day. The primary endpoint is change in physical function of the hand, measured with the Australian/Canadian Osteoarthritis Hand Index (AUSCAN).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

October 4, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 6, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2023

Completed
Last Updated

March 23, 2023

Status Verified

March 1, 2023

Enrollment Period

2.4 years

First QC Date

September 29, 2020

Last Update Submit

March 22, 2023

Conditions

Keywords

mittensheathand osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Change in hand physical function

    change in physical function is measured with the Australian/Canadian Osteoarthritis Hand Index (AUSCAN). AUSCAN is a validated questionnaire with 3 subscales assessing pain, hand stiffness and hand function during the last 48 hours. Each question is rated on a visual analog scale from 0 (no problems) to 100 (severe problems). The subscale function will be used.

    Baseline, week 6 (end-of-study)

Secondary Outcomes (5)

  • Change in stiffness

    Baseline, week 6

  • Change in tender and swollen joint count

    baseline, week 6

  • Change in hand pain

    Baseline, week 6

  • Change in global assessment of hand related problems

    Baseline, week 6

  • Change in grip strength

    Baseline, week 6

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

Activated mittens

Device: activated mittens

Control group

SHAM COMPARATOR

Deactivated mittens

Device: deactivated mittens

Interventions

activated mittens (with electronic heat)

Intervention group

deactivated mittens (without electronic heat)

Control group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • HOA with fulfillment of the ACR criteria:
  • a. Hand pain, aching or stiffness on most days the previous 4 weeks
  • And at least 3 of the following features:
  • Hard tissue enlargement of ≥2 of the 10 selected joints\*
  • Hard tissue enlargement of ≥2 of the 10 DIP joints
  • Fewer than 3 swollen metacarpophalangeal (MCP) joints
  • Deformity of at least 1 of 10 selected joints\* \*The 10 selected joints are the second and third DIP, the second and third PIP, and the first carpometacarpal joints of both hands.
  • AUSCAN Function ≥ 40 aggregated points (0-100 scale)
  • Willing and able to participate in all study visits
  • Able to understand and read Danish.

You may not qualify if:

  • Other diseases affecting the joints of the hand (Rheumatoid arthritis, Psoriatic arthritis, ect.)
  • Widespread or generalized pain syndrome (e.g. fibromyalgia)
  • Steroid injections in the finger joints within the last month
  • Other condition that in the opinion of the investigator makes the participant unsuitable for participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Artroseambulatoriet

Frederiksberg, 2000, Denmark

Location

Related Publications (1)

  • Bartholdy C, Dossing A, Stisen ZR, Nielsen SM, Christensen R, Danneskiold-Samsoe B, Bliddal H, Henriksen M, Ellegaard K. Effect of heated mittens on physical hand function in people with hand osteoarthritis: randomised controlled trial. BMJ. 2024 Dec 17;387:e078222. doi: 10.1136/bmj-2023-078222.

Study Officials

  • cecilie bartholdy, PhD

    The Parker institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
A designated person will number the all mittens using a randomization list. The rest of the study personnel (care provider, investigator, outcome assessor) will thereby not be aware of which mittens that functions and which that do not.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomised 1:1 to either intervention og control group by use of a randomization list
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

September 29, 2020

First Posted

October 6, 2020

Study Start

October 4, 2020

Primary Completion

March 7, 2023

Study Completion

March 7, 2023

Last Updated

March 23, 2023

Record last verified: 2023-03

Locations